|
|
NIMESULIDE
at
3rd World Congress World Institute of Pain (WIP)
Barcelona, 21-25 September, 2004
HELSINN SATELLITE SYMPOSIUM
23rd September - 12:00 -
13:30 (Room 5)
"The control of pain for a better compliance of the patients"
Helsinn announces its presence in the forthcoming
3rd
World Congress World Institute of Pain (WIP), which will
be held in Barcelona, Spain, from 21st to 25th September
2004.
Helsinn will actively participate in the event with a sponsored
satellite symposium (23rd September
2004, 12:00-13:30 in room 5), "The control of pain for a better compliance of
the patients", on one of the Group's principal products, nimesulide, a
non-steroidal, anti-inflammatory drug, indicated for the treatment of acute
pain, symptomatic treatment of painful osteoarthritis and dysmenorrhoea.
Please revert to the scientific programme of the symposium herebelow, with the
details of each presentation and relative speaker and chairpersons:
SCIENTIFIC
PROGRAMME
CHAIRPERSONS: K.D. RAINSFORD (UK), G. VARRASSI (I)
● C. Lampl (A) - Pain mechanisms and current management: what is the role of
NSAIDs?
● M. Bianchi (I) - New evidences on the efficacy of nimesulide in the
treatment of joint pain.
● A. Binning (UK) - Nimesulide in the treatment of acute pain: double-blind
comparative study in a post-operative setting.
● I. Bjarnason (UK) - Gastrointestinal safety aspects of NSAIDs:
controversial and non-controversial items.
|
|